Literature DB >> 18080089

Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives.

M Lesurtel1, C Soll, R Graf, P-A Clavien.   

Abstract

Beside its role as a neurotransmitter in the central nervous system, serotonin appears to be a central physiologic mediator of many gastrointestinal (GI) functions and a mediator of the brain-gut connection. By acting directly and via modulation of the enteric nervous system, serotonin has numerous effects on the GI tract. The main gut disturbances in which serotonin is involved are acute chemotherapy-induced nausea and vomiting, carcinoid syndrome and irritable bowel syndrome. Serotonin also has mitogenic properties. Platelet-derived serotonin is involved in liver regeneration after partial hepatectomy. In diseased liver, serotonin may play a crucial role in the progression of hepatic fibrosis and the pathogenesis of steatohepatitis. Better understanding of the role of the serotonin receptor subtypes and serotonin mechanisms of action in the liver and gut may open new therapeutic strategies in hepato-gastrointestinal diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18080089     DOI: 10.1007/s00018-007-7377-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  48 in total

1.  Important role of mucosal serotonin in colonic propulsion and peristaltic reflexes: in vitro analyses in mice lacking tryptophan hydroxylase 1.

Authors:  Dante J Heredia; Michael D Gershon; Sang Don Koh; Robert D Corrigan; Takanubu Okamoto; Terence K Smith
Journal:  J Physiol       Date:  2013-10-14       Impact factor: 5.182

2.  Brain serotonergic circuitries.

Authors:  Yves Charnay; Lucienne Léger
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

Review 3.  Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors.

Authors:  Javier Molina-Cerrillo; Teresa Alonso-Gordoa; Olga Martínez-Sáez; Enrique Grande
Journal:  Oncologist       Date:  2016-04-22

Review 4.  Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome.

Authors:  Pejman Katiraei; Gilberto Bultron
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

Review 5.  Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.

Authors:  Michelle C Janelsins; Mohamedtaki A Tejani; Charles Kamen; Anita R Peoples; Karen M Mustian; Gary R Morrow
Journal:  Expert Opin Pharmacother       Date:  2013-04       Impact factor: 3.889

Review 6.  Fibrosis and carcinoid syndrome: from causation to future therapy.

Authors:  Maralyn Druce; Andrea Rockall; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

7.  Automated mass spectrometric analysis of urinary and plasma serotonin.

Authors:  Wilhelmina H A de Jong; Marianne H L I Wilkens; Elisabeth G E de Vries; Ido P Kema
Journal:  Anal Bioanal Chem       Date:  2010-02-07       Impact factor: 4.142

Review 8.  A dialogue between the immune system and brain, spoken in the language of serotonin.

Authors:  Nicole L Baganz; Randy D Blakely
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

9.  Characterization of electroencephalographic and biochemical responses at 5-HT promoting drug-induced onset of serotonin syndrome in rats.

Authors:  Zhiyuan Ma; Mary Rudacille; Howard M Prentice; Rui Tao
Journal:  J Neurochem       Date:  2013-01-28       Impact factor: 5.372

10.  Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival.

Authors:  Vaibhav P Pai; Aaron M Marshall; Laura L Hernandez; Arthur R Buckley; Nelson D Horseman
Journal:  Breast Cancer Res       Date:  2009-11-10       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.